Message from Toronto - Deliver AIDS treatment and prevention

New England Journal of Medicine

Volumn 355, Issue 11, 2006, Pages 1081-1084

  Steinbrook, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CIRCUMCISION; CONDOM; CONFERENCE PAPER; DIAPHRAGM; DRUG EFFICACY; DRUG SAFETY; GENITAL HERPES; HEALTH CARE COST; HEALTH CARE SYSTEM; HERPES; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; VERTICAL TRANSMISSION; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; ANTI-RETROVIRAL AGENTS; DISEASE OUTBREAKS; DISEASE TRANSMISSION; HIV INFECTIONS; HUMANS; WORLD HEALTH;

EID: 33748710829     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp068167     Document Type: Conference Paper

References (5)

1. 2006 Report on the global AIDS epidemic. Geneva: UNAIDS, 2006. (Accessed August 22, 2006, at http://www.unaids.org/en/.)
2. Towards universal access by 2010. Geneva: World Health Organization, 2006. (Accessed August 22, 2006, at http://www.who.int/hiv.)
3. Global HIV Prevention Working Group. New approaches to HIV prevention. August 2006. (Accessed August 22, 2006, at http://www.kff.org/hivaids/ hiv081506pkg.cfm.)
4. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005;2:e298. [Erratum, PLoS Med 2006;3:e298.
5. Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006;368:531-6.